IBDEI16Q ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20150,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,20150,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,20151,0)
 ;;=C79.51^^84^929^113
 ;;^UTILITY(U,$J,358.3,20151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20151,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,20151,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,20151,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,20152,0)
 ;;=C79.52^^84^929^112
 ;;^UTILITY(U,$J,358.3,20152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20152,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,20152,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,20152,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,20153,0)
 ;;=C79.31^^84^929^114
 ;;^UTILITY(U,$J,358.3,20153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20153,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,20153,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,20153,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,20154,0)
 ;;=C79.72^^84^929^129
 ;;^UTILITY(U,$J,358.3,20154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20154,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,20154,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,20154,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,20155,0)
 ;;=C78.02^^84^929^133
 ;;^UTILITY(U,$J,358.3,20155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20155,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,20155,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,20155,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,20156,0)
 ;;=C78.7^^84^929^138
 ;;^UTILITY(U,$J,358.3,20156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20156,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,20156,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,20156,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,20157,0)
 ;;=C79.71^^84^929^151
 ;;^UTILITY(U,$J,358.3,20157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20157,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,20157,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,20157,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,20158,0)
 ;;=C78.01^^84^929^155
 ;;^UTILITY(U,$J,358.3,20158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20158,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,20158,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,20158,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,20159,0)
 ;;=C79.70^^84^929^106
 ;;^UTILITY(U,$J,358.3,20159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20159,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,20159,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,20159,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,20160,0)
 ;;=C78.00^^84^929^139
 ;;^UTILITY(U,$J,358.3,20160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20160,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,20160,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,20160,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,20161,0)
 ;;=D57.1^^84^929^182
 ;;^UTILITY(U,$J,358.3,20161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20161,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,20161,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,20161,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,20162,0)
 ;;=D75.1^^84^929^180
 ;;^UTILITY(U,$J,358.3,20162,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20162,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,20162,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,20162,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,20163,0)
 ;;=C90.30^^84^929^183
 ;;^UTILITY(U,$J,358.3,20163,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20163,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
